Digital Digital health’s rapid growth spurt comes home to roost With fears of a recession and inflation running high, the boom period for digital health apps looks to be waning.
Digital Pharma’s digital inflection point Billed as the world’s most influential technology event, this year’s CES show saw its first ever keynote from a healthcare company when Abbott CEO Robert Ford took to the stage in Las Vegas
Digital Making sense of differing digital health funding reports Digital health venture funding had a ridiculous, bonkers, blockbuster year.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends